Sandeep Talwar, MD
Clinical Cardiac Electrophysiology · Farmington, UTNPI 1922290915
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medical Device Business Services, Inc. at 54.8% of the total. Reporting peaked in 2021 at $20,061 and has fallen 57.0% since, to $8,632 in 2025.
Across 555 payments — averaging $146.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$45K
- Medtronic$13K
- Boston Scientific$13K
- Abbott$7K
- Biosense Webster, Inc.$3K
- Inspire Medical Systems, Inc.$189
- plus $1K from 18 others
What the payments were for
- Consulting fees$39,00048%
- Travel & lodging$20,50225%
- Food & beverage$21,90927%
- Education$1220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 41 | $44,664 |
| Medtronic(2 entities) | 124 | $12,983 |
| Boston Scientific | 160 | $12,586 |
| Abbott | 86 | $6,616 |
| Biosense Webster, Inc. | 107 | $3,301 |
| Inspire Medical Systems, Inc. | 2 | $189 |
| Pfizer | 8 | $138 |
| Baxter Healthcare | 2 | $134 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $132 |
| Impulse Dynamics (USA) Inc. | 2 | $128 |
| Abiomed | 1 | $102 |
| Cvrx, Inc. | 2 | $96 |
| Novartis | 4 | $78 |
| Biotronik Inc. | 2 | $78 |
| Amgen | 1 | $73 |
| Lantheus Medical Imaging, Inc. | 2 | $52 |
| Cook Medical LLC | 1 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Stryker | 1 | $17 |
| Preventice Services, LLC | 1 | $15 |
| Cardiva Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$37,528
- Carto 3 System$7,603
- Farapulse$3,650
- Micra$2,495
- WATCHMAN Access System$1,868
- Cardiac Mapping System$1,079
- ENSITE$834
- AMPLATZER AMULET$819
- EnSite Precision Cardiac Mapping System$784
- Watchman$537
- AURORA EV-ICD MRI SURESCAN$332
- COBALT DR MRI SURESCAN$323
- OCTARAY MAPPING CATHETER$291
- NA$197
- Ensite Cardiac Mapping System$161
- ACCENT$152
- Azure$147
- Inspire$146
- SelectSecure$141
- QDOT MICRO Catheter$135
How this compares
$81,533 in reported general payments places this provider in the 80th percentile of 29 clinical cardiac electrophysiology providers in Utah.
See all clinical cardiac electrophysiology providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 181 | $178,505 |
| XareltoRivaroxaban | 46 | $58,748 |
| FarxigaDapagliflozin Propanediol | 44 | $39,637 |
| EntrestoSacubitril/Valsartan | 15 | $20,571 |
| Amiodarone Hcl | 228 | $2,831 |
| Flecainide Acetate | 55 | $1,996 |
| Chlorthalidone | 36 | $725 |
| ClopidogrelClopidogrel Bisulfate | 58 | $696 |
| Potassium Chloride | 42 | $646 |
| Carvedilol | 53 | $631 |
| Metoprolol Succinate | 44 | $577 |
| Losartan Potassium | 86 | $569 |
| Diltiazem 24hr ErDiltiazem Hcl | 16 | $439 |
| Amlodipine Besylate | 43 | $295 |
| Metoprolol Tartrate | 38 | $253 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $138 | $178,505181 claims |
| Johnson & JohnsonXarelto | $18 | $58,74846 claims |
| NovartisEntresto | $78 | $20,57115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 29 clinical cardiac electrophysiology providers in Utah.
Other clinical cardiac electrophysiology in Farmington
- Ravi RanjanSalt Lake City$345K
- John DaySalt Lake City$313K
- Chun HwangProvo$289K
- Roger FreedmanSalt Lake City$177K
- Douglas PackerMurray$169K
- Michael CutlerMurray$70K
- Nischala NannapaneniSalt Lake City$57K
- Weston HarknessSt George$49K
- Helge LehmannSalt Lake City$49K
- Richard SheltonSalt Lake City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.